EUVIMEDEUVIMED entdecken
Open Access

SYNCRIP drives ferroptosis resistance and metabolic activation via SIRT1 and HK2 in glioblastoma

Hyeon Ji Kim, Hyo-Jin Song, Yu Gyung Kim, Mingyu Kang, Tae-Jun Kim, Jin-Seok Byun, Do-Yeon Kim

International Journal of Biological Sciences · 13.07.2026 · 22 (12) · 6670-6688

DOI: 10.7150/ijbs.127096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 13.07.2026. Verfasst von Hyeon Ji Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea. Hauptthemen laut MEDLINE: Ferroptosis, Sirtuin 1, Glioblastoma, Hexokinase. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA. Meanwhile, loss of SYNCRIP leads to reduced SIRT1 expression, accumulation of reactive oxygen species (ROS), and induction of ferroptosis. Notably, restoration of SIRT1 rescues cells from ferroptotic cell death, supporting the critical role of SIRT1 in SYNCRIP-mediated ferroptosis resistance. SYNCRIP also enhances hexokinase 2 (HK2) expression through transcriptional activation and internal ribosome entry site (IRES)-mediated translation, thereby promoting glycolytic activity in GBM. Furthermore, depletion of SYNCRIP results in mitochondrial dysfunction and impairs GBM cell migration and invasion by downregulating epithelial-mesenchymal transition (EMT)-associated factors. Collectively, these findings suggest that SYNCRIP is a key regulator of GBM progression by maintaining metabolic homeostasis and ferroptosis resistance, highlighting SYNCRIP as a potential therapeutic target in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSirtuin 1GlioblastomaHexokinaseRNA-Binding ProteinsHumansCell Line, TumorReactive Oxygen SpeciesGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionBrain Neoplasms

Stichwörter der Autor:innen

HK2IRESSIRT1SYNCRIPferroptosistranscription

Substanzen

Sirtuin 1HexokinaseSIRT1 protein, humanHK2 protein, humanReactive Oxygen SpeciesRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.
  • Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 10408, Gyeonggi-do, Republic of Korea.
  • Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
  • Department of Oral Medicine, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.

Zitieren

APA

Kim, H. J., Song, H. J., Kim, Y. G., Kang, M., Kim, T. J., Byun, J. S., & Kim, D. Y. (2026). SYNCRIP drives ferroptosis resistance and metabolic activation via SIRT1 and HK2 in glioblastoma. International Journal of Biological Sciences, 22(12), 6670-6688. https://doi.org/10.7150/ijbs.127096

Vancouver

Kim HJ, Song HJ, Kim YG, Kang M, Kim TJ, Byun JS, et al. SYNCRIP drives ferroptosis resistance and metabolic activation via SIRT1 and HK2 in glioblastoma. International Journal of Biological Sciences. 2026;22(12):6670-6688. doi:10.7150/ijbs.127096

BibTeX
@article{Kim2026,
  author = {Kim, Hyeon Ji and Song, Hyo-Jin and Kim, Yu Gyung and Kang, Mingyu and Kim, Tae-Jun and Byun, Jin-Seok and Kim, Do-Yeon},
  title = {SYNCRIP drives ferroptosis resistance and metabolic activation via SIRT1 and HK2 in glioblastoma},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {12},
  pages = {6670--6688},
  doi = {10.7150/ijbs.127096}
}
Kostenlos starten →